BioConvergence and Creapharm have partnered in an effort to provide customers with lower costs, reduced risks, and increased control of projects. The partnership — called the “Transatlantic Bridge” — aims to combine pharmaceutical services and provide integrated, customized services with innovative, transparent, and effective solutions, without adding the resources and costs associated with managing multiple partners. The “Transatlantic Bridge” provides access to North America from Europe and...